MECP2 (methyl CpG binding protein 2 (Rett syndrome)) is a gene that provides instructions for making the protein MeCP2 that appears to be essential for the normal function of nerve cells. The protein seems to be particularly important for mature nerve cells, where it is present in high levels. The MeCP2 protein is likely involved in turning off (or "silencing") several other genes. This prevents the genes from making proteins when they are not needed. The MeCP2 protein binds to DNA at regions called CpG islands, which frequently occur near the beginning of a gene. The MeCP2 protein then interacts with other proteins to form a complex that turns off the gene. Researchers have not yet determined which genes are targeted by the MeCP2 protein, but such genes are probably important for the normal function of the central nervous system.
The MECP2 gene is located on the long (q) arm of the X chromosome at position 28, from base pair 152,808,110 to base pair 152,878,611.
Mutations in the MECP2 gene have also been identified in people with several other disorders affecting the central nervous system. For example, MECP2 mutations are associated with some cases of moderate to severe X-linked mental retardation. Mutations in the gene have also been found in males with severe brain dysfunction (neonatal encephalopathy) who live only into early childhood. In addition, several people with features of both Rett syndrome and Angelman syndrome (a condition characterized by mental retardation, problems with movement, and inappropriate laughter and excitability) have mutations in the MECP2 gene. Lastly, MECP2 mutations or changes in the gene's activity have been reported in some cases of autism (a developmental disorder that affects communication and social interaction).